Sparsentan, a medication, may be a potential new treatment option for Focal Segmental Glomerulosclerosis (FSGS), a rare kidney disorder that can lead to kidney failure. A University of Minnesota Medical School-led study found that FSGS patients treated with sparsentan showed improved kidney function and displayed significant reductions in proteinuria.

Microsoft Teams To Block Screen Capture During Meetings
Microsoft will launch a “Prevent Screen Capture” feature for Teams in July 2025 to block unauthorized screenshots during meetings, addressing a key vulnerability. The feature